Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Stock Holdings Lifted by Jennison Associates LLC

Jennison Associates LLC lifted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 26.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,148,755 shares of the company’s stock after buying an additional 238,114 shares during the quarter. Jennison Associates LLC’s holdings in Acadia Healthcare were worth $89,327,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in ACHC. Handelsbanken Fonder AB boosted its holdings in shares of Acadia Healthcare by 9.8% during the fourth quarter. Handelsbanken Fonder AB now owns 15,674 shares of the company’s stock worth $1,219,000 after purchasing an additional 1,400 shares during the period. abrdn plc bought a new position in shares of Acadia Healthcare in the fourth quarter valued at approximately $7,847,000. Tranquility Partners LLC raised its position in shares of Acadia Healthcare by 5.3% in the fourth quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock valued at $264,000 after purchasing an additional 170 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Acadia Healthcare by 5.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 19,976 shares of the company’s stock valued at $1,553,000 after purchasing an additional 1,056 shares during the period. Finally, Strs Ohio increased its position in Acadia Healthcare by 10.9% during the fourth quarter. Strs Ohio now owns 82,288 shares of the company’s stock worth $6,398,000 after acquiring an additional 8,100 shares during the period.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 2.80% of the company’s stock.

Analyst Ratings Changes

ACHC has been the topic of several analyst reports. UBS Group boosted their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. Mizuho upped their price target on Acadia Healthcare from $77.00 to $84.00 and gave the company a “neutral” rating in a research note on Wednesday, March 6th. Barclays assumed coverage on Acadia Healthcare in a research note on Wednesday, March 6th. They set an “overweight” rating and a $100.00 target price for the company. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $94.75.

Acadia Healthcare Stock Performance

ACHC stock opened at $70.26 on Tuesday. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The business’s fifty day moving average price is $78.91 and its two-hundred day moving average price is $77.71. Acadia Healthcare Company, Inc. has a fifty-two week low of $66.49 and a fifty-two week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The company had revenue of $742.80 million for the quarter, compared to analysts’ expectations of $727.60 million. During the same quarter last year, the business earned $0.70 earnings per share. Acadia Healthcare’s revenue was up 10.0% on a year-over-year basis. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.